Holen Sie sich die Stockscreener-App
172.24
0.06%
0.10
Handel nachbörslich:
172.24
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$172.14
Offen:
$171.27
24-Stunden-Volumen:
687.94K
Relative Volume:
0.77
Marktkapitalisierung:
$19.05B
Einnahmen:
$9.54B
Nettoeinkommen (Verlust:
$841.00M
KGV:
23.15
EPS:
7.44
Netto-Cashflow:
$1.02B
1W Leistung:
+2.06%
1M Leistung:
+12.83%
6M Leistung:
+12.60%
1J Leistung:
+35.91%
1-Tages-Spanne:
$170.58
$172.91
1-Wochen-Bereich:
$166.15
$172.91
52-Wochen-Spanne:
$123.66
$172.91
Quest Diagnostics Inc Stock (DGX) Company Profile
Firmenname
Quest Diagnostics Inc
Sektor
Branche
Telefon
(973) 520-2700
Adresse
500 PLAZA DRIVE, SECAUCUS
Vergleichen Sie DGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
172.24 | 19.05B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Fortgesetzt | Evercore ISI | In-line |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-29 | Eingeleitet | Piper Sandler | Neutral |
| 2023-05-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-01-23 | Eingeleitet | Evercore ISI | In-line |
| 2022-11-17 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-23 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-02 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Hochstufung | UBS | Neutral → Buy |
| 2021-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Hochstufung | Argus | Hold → Buy |
| 2020-07-29 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-09 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Herabstufung | Goldman | Neutral → Sell |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-03-18 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-01-31 | Herabstufung | Argus | Buy → Hold |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest Diagnostics SVP Michael Prevoznik sells $103,277 in stock - Investing.com
Quest Diagnostics SVP Plewman sells $54,307 in stock - Investing.com India
New York State Teachers Retirement System Cuts Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (NYSE:DGX) Sets New 1-Year HighShould You Buy? - MarketBeat
Principal Financial Group Inc. Acquires 104,495 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by Van ECK Associates Corp - MarketBeat
Vontobel Holding Ltd. Has $7.14 Million Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Chevy Chase Trust Holdings LLC Has $15.36 Million Stake in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
In vitro diagnostics Market Poised for Significant Growth to Reach value of USD 133.24 Billion from 2025 to 2034 - GlobeNewswire Inc.
Quest Diagnostics stock hits 52-week high at $171.42 By Investing.com - Investing.com Nigeria
Quest Diagnostics stock hits 52-week high at $171.42 - Investing.com
Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by Kentucky Retirement Systems Insurance Trust Fund - MarketBeat
Is There An Opportunity With Quest Diagnostics Incorporated's (NYSE:DGX) 50% Undervaluation? - Yahoo Finance UK
Rhumbline Advisers Sells 8,647 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Empowered Funds LLC - MarketBeat
Savant Capital LLC Raises Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
MOKAN Wealth Management Inc. Makes New Investment in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Sheaff Brock Investment Advisors LLC Makes New Investment in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Stock Holdings Reduced by Avestar Capital LLC - MarketBeat
How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks? - MSN
Earnings Preview: What to Expect From Quest Diagnostics' Report - MSN
Quest Diagnostics (NYSE:DGX) Sets New 12-Month HighHere's What Happened - MarketBeat
Palumbo Wealth Management LLC Acquires 2,396 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
State of Alaska Department of Revenue Trims Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
1,506 Shares in Quest Diagnostics Incorporated (NYSE:DGX) Bought by Kentucky Trust Co - MarketBeat
WCM Investment Management LLC Acquires 1,647 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Grail shares jump on partnership with Quest Diagnostics - Mugglehead
SVP for Diagnostic Services Plewman Patrick was granted 2,042 shares, increasing direct ownership by 12% to 18,402 units (SEC Form 4) - Quantisnow
Weatherly Asset Management L. P. Sells 2,930 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Cambiar Investors LLC Sells 9,196 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Yousif Capital Management LLC Has $2.77 Million Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics to Host Investor Day on March 19, 2025 - PR Newswire
Grail rallies 30% in wake of Quest agreement (GRAL:NASDAQ) - Seeking Alpha
Grail and Quest Diagnostics to offer Galleri test to US physicians - Medical Device Network
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Grail Shares Spiked Wednesday: What's Going On? - Benzinga
Argus Adjusts Price Target on Quest Diagnostics to $185 From $175, Maintains Buy Rating - Marketscreener.com
Grail And Quest Diagnostics Provide Grail's Galleri Multi-Cancer Early Detection (MCED) Test - Marketscreener.com
Revolutionary Cancer Detection Test Now Available at Quest Labs NationwideEarly Detection for 50+ Types - StockTitan
Self-Testing Market Projected To Witness Substantial Growth, 2025-2032:Quest Diagnostics, Bionime Corporation, - EIN News
Quest Diagnostics Incorporated (NYSE:DGX) SVP Mark E. Delaney Sells 403 Shares - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Director Sells $205,712.50 in Stock - MarketBeat
GHP Investment Advisors Inc. Boosts Stake in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term - Nasdaq
Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats - Nasdaq
Finanzdaten der Quest Diagnostics Inc-Aktie (DGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.50%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):